InvestorsHub Logo
Followers 11
Posts 1538
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Thursday, 02/26/2015 2:52:44 PM

Thursday, February 26, 2015 2:52:44 PM

Post# of 146291
Hey Lief... Is Seymour trying to confuse us? I thought you said they were manufacturing cGLP? LOL

The Company has previously reported that it completed the acquisition of the state-of-the-art nanomedicines manufacturing facility at 1 Controls Drive, Shelton, CT, from Inno-Haven, LLC, by reimbursing Inno-Haven for the costs incurred. This facility will be capable of producing any of the Company's drug candidates in a cGMP-compliant manner in multi-kilogram quantities. This facility will be able to provide the cGMP clinical drug substances for the Company's future human clinical studies. ("c-GMP"= current Good Manufacturing Practices).

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News